Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $65
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Wells Fargo analyst James Feldman maintains National Health Investors (NYSE:NHI) with a Equal-Weight and lowers the price target from $68 to $65.
Wells Fargo analyst James Feldman maintains National Health Investors (NYSE:NHI) with a Equal-Weight and lowers the price target from $68 to $65.
